Send to

Choose Destination
Br J Obstet Gynaecol. 1990 Aug;97(8):690-4.

Levonorgestrel-releasing intrauterine device in the treatment of menorrhagia.

Author information

Department of Obstetrics and Gynaecology, East Hospital, University of Göteborg, Sweden.


In 20 women with menorrhagia (greater than 80 ml blood loss per menstrual period) a levonorgestrel-releasing intrauterine device (Lng-IUCD) was inserted. Menstrual blood loss (MBL) was measured in two consecutive cycles before the device was inserted and after 3, 6 and 12 months of use. MBL was significantly reduced after 3 months (86%) and after 12 months the reduction was 97%. There was a significant increase (P less than 0.001) in serum ferritin during the first year of Lng-IUCD use. The Lng-IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center